207 related articles for article (PubMed ID: 35088915)
1. A novel DPP-4 inhibitor Gramcyclin A attenuates cognitive deficits in APP/PS1/tau triple transgenic mice via enhancing brain GLP-1-dependent glucose uptake.
Li Z; Zhang Y; Meng X; Li M; Cao W; Yang J; Xu X; Liu W; Li W; Cai Q; Wang S; Ma G; Liu Z; Huang G
Phytother Res; 2022 Mar; 36(3):1297-1309. PubMed ID: 35088915
[TBL] [Abstract][Full Text] [Related]
2. Intranasal 15d-PGJ2 ameliorates brain glucose hypometabolism via PPARγ-dependent activation of PGC-1α/GLUT4 signalling in APP/PS1 transgenic mice.
Li Z; Zhang Y; Zheng Y; Liu W; Zhang X; Li W; Zhang D; Cai Q; Wang S; Meng X; Huang G
Neuropharmacology; 2021 Sep; 196():108685. PubMed ID: 34175325
[TBL] [Abstract][Full Text] [Related]
3. DPP-4 inhibitor improves learning and memory deficits and AD-like neurodegeneration by modulating the GLP-1 signaling.
Chen S; Zhou M; Sun J; Guo A; Fernando RL; Chen Y; Peng P; Zhao G; Deng Y
Neuropharmacology; 2019 Oct; 157():107668. PubMed ID: 31199957
[TBL] [Abstract][Full Text] [Related]
4. Increasing brain glucose uptake by Gypenoside LXXV ameliorates cognitive deficits in a mouse model of diabetic Alzheimer's disease.
Meng X; Zhang Y; Li Z; Ma G; Zhang X; Zhang D; Cao W; Wang S; Cai Q; Cui P; Huang G
Phytother Res; 2023 Feb; 37(2):611-626. PubMed ID: 36325883
[TBL] [Abstract][Full Text] [Related]
5. Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease.
Kosaraju J; Holsinger RMD; Guo L; Tam KY
Mol Neurobiol; 2017 Oct; 54(8):6074-6084. PubMed ID: 27699599
[TBL] [Abstract][Full Text] [Related]
6. Increasing brain glucose metabolism by ligustrazine piperazine ameliorates cognitive deficits through PPARγ-dependent enhancement of mitophagy in APP/PS1 mice.
Li Z; Meng X; Ma G; Liu W; Li W; Cai Q; Wang S; Huang G; Zhang Y
Alzheimers Res Ther; 2022 Oct; 14(1):150. PubMed ID: 36217155
[TBL] [Abstract][Full Text] [Related]
7. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
8. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
Ettcheto M; Petrov D; Pedrós I; Alva N; Carbonell T; Beas-Zarate C; Pallas M; Auladell C; Folch J; Camins A
J Alzheimers Dis; 2016 Jul; 54(1):233-51. PubMed ID: 27567882
[TBL] [Abstract][Full Text] [Related]
10. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice.
Zhou D; Liu H; Li C; Wang F; Shi Y; Liu L; Zhao X; Liu A; Zhang J; Wang C; Chen Z
Metab Brain Dis; 2016 Jun; 31(3):693-703. PubMed ID: 26883430
[TBL] [Abstract][Full Text] [Related]
12. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
Liu HL; Zhao G; Zhang H; Shi LD
Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
[TBL] [Abstract][Full Text] [Related]
13. Long-term running exercise improves cognitive function and promotes microglial glucose metabolism and morphological plasticity in the hippocampus of APP/PS1 mice.
Zhang SS; Zhu L; Peng Y; Zhang L; Chao FL; Jiang L; Xiao Q; Liang X; Tang J; Yang H; He Q; Guo YJ; Zhou CN; Tang Y
J Neuroinflammation; 2022 Feb; 19(1):34. PubMed ID: 35123512
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
[TBL] [Abstract][Full Text] [Related]
15.
Wan L; Zhang Q; Luo H; Xu Z; Huang S; Yang F; Liu Y; Mahaman YAR; Ke D; Wang Q; Liu R; Wang JZ; Shu X; Wang X
Aging (Albany NY); 2020 Jul; 12(13):13422-13436. PubMed ID: 32652518
[No Abstract] [Full Text] [Related]
16. OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice.
Yuan C; Guo X; Zhou Q; Du F; Jiang W; Zhou X; Liu P; Chi T; Ji X; Gao J; Chen C; Lang H; Xu J; Liu D; Yang Y; Qiu S; Tang X; Chen G; Zou L
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):161-180. PubMed ID: 30389579
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease.
Tai J; Liu W; Li Y; Li L; Hölscher C
Brain Res; 2018 Jan; 1678():64-74. PubMed ID: 29050859
[TBL] [Abstract][Full Text] [Related]
18. Notopterygium incisum extract (NRE) rescues cognitive deficits in APP/PS1 Alzhneimer's disease mice by attenuating amyloid-beta, tau, and neuroinflammation pathology.
Jiang XW; Liu WW; Wu YT; Wu Q; Lu HY; Xu ZH; Gao HY; Zhao QC
J Ethnopharmacol; 2020 Mar; 249():112433. PubMed ID: 31783135
[TBL] [Abstract][Full Text] [Related]
19. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
[TBL] [Abstract][Full Text] [Related]
20. DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer's disease.
Cao Y; Hölscher C; Hu MM; Wang T; Zhao F; Bai Y; Zhang J; Wu MN; Qi JS
Eur J Pharmacol; 2018 May; 827():215-226. PubMed ID: 29551659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]